NIMV

AcronymDefinition
NIMVNon-Invasive Mechanical Ventilation
NIMVNasal Intermittent Mandatory Ventilation (respiratory treatment)
NIMVNavel Infectious Mottling Virus
References in periodicals archive ?
1--Akut sol kalp yetersizligi (kardiyojenik pulmoner odem) tedavisinde NIMV kullanimi
Son 20 yildir klinik pratikte olan NIMV uygulamasi ile entubasyon ve mekanik ventilasyondan kaynaklanan bazi komplikasyonlardan kacinmak ve mortaliteyi azaltmak mumkun olabilmektedir.
Kardiyak veya solunum arresti, akciger disi organ yetersizligi, agir ensefalopati, agir ust gastrointestinal sistem (GIS) kanamasi, hemodinamik veya elektriksel instabilite, yuz cerrahisi travmasi veya orofasyal anormallik, ust solunum yolu obstruksiyonu, hastanin koopere olamamasi ve havayollarini koruyamamasi (oksurememe), aspirasyon riskinin yuksek olmasi durumlarinda NIMV kontrendikedir.
Hastanin bilincinin kapali olmasi (arrest gecirmis, kardiyopulmoner resusitasyon sonrasi), somnolans veya yuz maskesine elverisli olmamasi (orofasyal anormallik) hallerinde, NIMV basarisizliginda ya da kontrendikasyonlarinda, solunum sayisi >35/dk, derin hipoksi (Pa[O.sub.2]<40 mmHg), ileri asidoz (pH<7.25), hiperkapni (PaC[O.sub.2]>60 mmHg), sok, metabolik bozukluk veya sepsis gibi durumlarda IMV endikasyonu vardir.
Kalp yetersizligi hastalarinda, NIMV tedavisinin solunum kaslari uzerinde de yararli etkileri oldugu gosterilmistir (12, 13).
The usefulness of NIMV (either non-invasive positive pressure ventilation [NPPV] or continuous positive airway pressure [CPAP]) in the respiratory management of trauma patients has still not been sufficiently investigated on a large scale.
According to the British Thoracic Society guidelines from 2002 (1), the indications and efficacy of NIMV in trauma-induced respiratory insufficiency were inconsistent and merely received a low-grade recommendation.
Factors that may account for the scarce evidence of the significant benefit of NIMV in trauma patients include the lack of uniformity, standardisation and design of various NIMV trials, the wide range of different traumatic events after which it was attempted and the low number of patients with significant hypoxemia included in the trials.
When evaluating the benefits of NIMV, the aetiology of acute respiratory failure (ARF) may become an important determinant of the final outcome, which likely explains the variable outcomes of NIMV application in various diseases and severities of lung injury.